These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 16904608

  • 1. pVHL's kryptonite: E2-EPF UCP.
    Ohh M.
    Cancer Cell; 2006 Aug; 10(2):95-7. PubMed ID: 16904608
    [Abstract] [Full Text] [Related]

  • 2. Egr-1 and serum response factor are involved in growth factors- and serum-mediated induction of E2-EPF UCP expression that regulates the VHL-HIF pathway.
    Lim JH, Jung CR, Lee CH, Im DS.
    J Cell Biochem; 2008 Nov 01; 105(4):1117-27. PubMed ID: 18780286
    [Abstract] [Full Text] [Related]

  • 3. E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis.
    Jung CR, Hwang KS, Yoo J, Cho WK, Kim JM, Kim WH, Im DS.
    Nat Med; 2006 Jul 01; 12(7):809-16. PubMed ID: 16819549
    [Abstract] [Full Text] [Related]

  • 4. E2-EPF UCP regulates stability and functions of missense mutant pVHL via ubiquitin mediated proteolysis.
    Park KS, Kim JH, Shin HW, Chung KS, Im DS, Lim JH, Jung CR.
    BMC Cancer; 2015 Oct 26; 15():800. PubMed ID: 26503325
    [Abstract] [Full Text] [Related]

  • 5. pVHL mediates K63-linked ubiquitination of nCLU.
    Xue J, Lv DD, Jiao S, Zhao W, Li X, Sun H, Yan B, Fan L, Hu RG, Fang J.
    PLoS One; 2012 Oct 26; 7(4):e35848. PubMed ID: 22532874
    [Abstract] [Full Text] [Related]

  • 6. Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression.
    Lim JH, Kim DG, Yu DY, Kang HM, Noh KH, Kim DS, Park D, Chang TK, Im DS, Jung CR.
    Cell Mol Life Sci; 2019 Jul 26; 76(13):2647-2662. PubMed ID: 30903204
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.
    Maynard MA, Ohh M.
    Am J Nephrol; 2004 Jul 26; 24(1):1-13. PubMed ID: 14654728
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
    Tanimoto K, Makino Y, Pereira T, Poellinger L.
    EMBO J; 2000 Aug 15; 19(16):4298-309. PubMed ID: 10944113
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha.
    Kong X, Lin Z, Liang D, Fath D, Sang N, Caro J.
    Mol Cell Biol; 2006 Mar 15; 26(6):2019-28. PubMed ID: 16507982
    [Abstract] [Full Text] [Related]

  • 12. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M, da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU, Houlston RS, Richards FM, Latif F, Maher ER.
    Cancer Res; 2002 Jul 01; 62(13):3803-11. PubMed ID: 12097293
    [Abstract] [Full Text] [Related]

  • 13. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner.
    Flügel D, Görlach A, Michiels C, Kietzmann T.
    Mol Cell Biol; 2007 May 01; 27(9):3253-65. PubMed ID: 17325032
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein.
    Corn PG, McDonald ER, Herman JG, El-Deiry WS.
    Nat Genet; 2003 Nov 01; 35(3):229-37. PubMed ID: 14556007
    [Abstract] [Full Text] [Related]

  • 16. Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization.
    Zheng X, Ruas JL, Cao R, Salomons FA, Cao Y, Poellinger L, Pereira T.
    Mol Cell Biol; 2006 Jun 01; 26(12):4628-41. PubMed ID: 16738327
    [Abstract] [Full Text] [Related]

  • 17. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
    Mole DR, Maxwell PH, Pugh CW, Ratcliffe PJ.
    IUBMB Life; 2001 Jul 01; 52(1-2):43-7. PubMed ID: 11795592
    [Abstract] [Full Text] [Related]

  • 18. Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressor.
    Grosfeld A, Stolze IP, Cockman ME, Pugh CW, Edelmann M, Kessler B, Bullock AN, Ratcliffe PJ, Masson N.
    J Biol Chem; 2007 May 04; 282(18):13264-9. PubMed ID: 17339318
    [Abstract] [Full Text] [Related]

  • 19. Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha/2alpha is mediated through chelation of iron.
    Park SS, Bae I, Lee YJ.
    J Cell Biochem; 2008 Apr 15; 103(6):1989-98. PubMed ID: 17973296
    [Abstract] [Full Text] [Related]

  • 20. The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing.
    Kaelin WG.
    Cold Spring Harb Symp Quant Biol; 2005 Apr 15; 70():159-66. PubMed ID: 16869749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.